Li L - Search Results

1

Pyrotinib-based treatments in HER2-positive breast cancer patients with brain metastases.

Ma X, Li Y, Li L, Gao C, Liu D, Li H, Zhao Z, Zhao B. Ma X, et al. Among authors: li y, li h, li l. Ann Med. 2022 Dec;54(1):3085-3095. doi: 10.1080/07853890.2022.2139411. Ann Med. 2022. PMID: 36331291 Free PMC article.

2

Prognostic and Predictive Markers for Early Stage Triple-Negative Breast Cancer Treated With Platinum-Based Neoadjuvant Chemotherapy.

Zhao Z, Li L, He M, Li Y, Ma X, Zhao B. Zhao Z, et al. Among authors: li y, li l. Cancer Med. 2024 Oct;13(20):e70336. doi: 10.1002/cam4.70336. Cancer Med. 2024. PMID: 39445528 Free PMC article.

3

Targeted therapy in HER2-positive breast cancer.

Li SG, Li L. Li SG, et al. Among authors: li l. Biomed Rep. 2013 Jul;1(4):499-505. doi: 10.3892/br.2013.95. Epub 2013 Apr 18. Biomed Rep. 2013. PMID: 24648975 Free PMC article. Review.

4

Diagnostic Value of Serum Concentration and Integrity of Circulating Cell-Free DNA in Breast Cancer: A Comparative Study With CEA and CA15-3.

Tang Z, Li L, Shen L, Shen X, Ju S, Cong H. Tang Z, et al. Among authors: li l. Lab Med. 2018 Oct 11;49(4):323-328. doi: 10.1093/labmed/lmy019. Lab Med. 2018. PMID: 29701836

5

Effects of antibiotics on immunotherapy in patients with metastatic nonsmall cell lung cancer.

Hu T, Li L, Cui J, Song X, Zhu H, Hou ZW, Yuan S. Hu T, et al. Among authors: li l. Eur J Cancer Prev. 2024 Sep 20. doi: 10.1097/CEJ.0000000000000912. Online ahead of print. Eur J Cancer Prev. 2024. PMID: 39302841

6

Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report.

Liu Y, Zhu J, Wei X, Yang D, Li S, Qian X, Li L. Liu Y, et al. Among authors: li s, li l. J Ovarian Res. 2022 Dec 3;15(1):127. doi: 10.1186/s13048-022-01069-y. J Ovarian Res. 2022. PMID: 36463302 Free PMC article.

7

Recurrence/prognosis estimation using a molecularly positive surgical margin-based model calls for alternative curative strategies in pIIIA/N2 NSCLC.

Li L, He K, Zhou T, Xu Y, Pang J, Yu Q, Gao Y, Shi H, Zhu H, Li M, Yu J, Yuan S. Li L, et al. Among authors: li m. Mol Oncol. 2024 Jun;18(6):1649-1664. doi: 10.1002/1878-0261.13600. Epub 2024 Feb 7. Mol Oncol. 2024. PMID: 38327028 Free PMC article.

8

Serum miR-20a is a promising biomarker for gastric cancer.

Yang R, Fu Y, Zeng Y, Xiang M, Yin Y, Li L, Xu H, Zhong J, Zeng X. Yang R, et al. Among authors: li l. Biomed Rep. 2017 Apr;6(4):429-434. doi: 10.3892/br.2017.862. Epub 2017 Feb 20. Biomed Rep. 2017. PMID: 28413641 Free PMC article.

9

Alu-based cell-free DNA: a novel biomarker for screening of gastric cancer.

Qian C, Ju S, Qi J, Zhao J, Shen X, Jing R, Yu J, Li L, Shi Y, Zhang L, Wang Z, Cong H. Qian C, et al. Among authors: li l. Oncotarget. 2016 Aug 5;8(33):54037-54045. doi: 10.18632/oncotarget.11079. eCollection 2017 Aug 15. Oncotarget. 2016. PMID: 28903321 Free PMC article.

10

Dose-Volume Constraints Parameters for Lung Tissue in Thoracic Radiotherapy Following Immune Checkpoint Inhibitor Treatment.

Wang K, Yang F, Feng C, Xu F, Li L, Duan J, Yuan S. Wang K, et al. Among authors: li l. J Inflamm Res. 2024 Oct 9;17:7141-7154. doi: 10.2147/JIR.S484489. eCollection 2024. J Inflamm Res. 2024. PMID: 39398227 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97,699 results

Search Page

Filters